SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $1,997,798,996 |
| Positions | 43 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| REVOLUTION MEDICINES INC | RVMD | COM | $482,682,924 | 2,577,333 |
| RELAY THERAPEUTICS INC | RLAY | COM | $300,019,340 | 16,035,240 |
| GENEDX HOLDINGS CORP | WGS | COM CL A | $254,496,809 | 3,707,164 |
| BIOLIFE SOLUTIONS INC | BLFS | COM NEW | $131,457,200 | 4,655,000 |
| ILLUMINA INC | ILMN | COM | $93,189,900 | 530,000 |
| STANDARD BIOTOOLS INC | LAB | COM | $73,042,478 | 88,783,856 |
| STRUCTURE THERAPEUTICS INC | GPCR | SPONSORED ADS | $63,062,250 | 1,175,000 |
| DENALI THERAPEUTICS INC | DNLI | COM | $52,597,400 | 2,045,000 |
| NEUROGENE INC | NGNE | COM | $48,601,603 | 1,545,361 |
| BEAM THERAPEUTICS INC | BEAM | COM | $46,332,000 | 1,350,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.